. These transplants can be freed of malignant cells (purging) when required by detection of minimal residual disease. Neuroblastoma is a disease with focal BM involvement and multiple biopsies would be more appropriate than aspirates for detecting low levels of tumour cells (Franklin & Pritchard, 1983; Bostrom et al., 1985 which selectively bind to cells of neuroectodermal origin have also been developed (Reynolds et al., 1982; Kemshead et al., 1983; Allan et al., 1983; Donner et al., 1985) . Two of these antibodies were used in an indirect immunofluorescence assay to confirm and extend the detection of neuroblastoma cells in suspensions of BM cells. In this paper we assess the relative value of cytological and histological investigations and the contribution of immunological analysis to neuroblastoma cell detection in the BM.
Patients and methods
Only stage IV neuroblastoma (diagnosed on classical criteria previously reported by Philip et al., 1985a,b) (at 70g for 5 min in a Shandon cytospin); these were air dried and stained with MGG, as described by Bayle et al. (1985) .
Immunological analysis Immunological analysis was performed on mononuclear cells (BM aspirations on heparin and ficoll separation as above), resuspended in PBS and stained by indirect immunofluorescence, as previously described (Favrot et al., 1984) . The 2 monoclonal antibodies UJ13A and HSAN 1-2 bind to neuroblastoma; they were kindly provided by J.T. Kemshead (Allan et al., 1983; Kenshead et al., 1983) and L.P. Reynolds (Reynolds et al., 1982) respectively. In BM taken from healthy donors, Table I ). In the remaining 9 abnormal cases (patients C.P. and D.A. in Table I ) , relapsed within 3 weeks of the study whilst on therapy and both the aspirates and trephines have become positive. In 4 patients, BM was harvested for autografting and 5 to 10% UJ13A positive cells were found before the purging procedure. These were isolated cells in 3 cases, clumps in one case. These cells were clearly eliminated by the immunomagnetic purging process which was subsequently used to cleanse the BM. These patients relapsed 5, 5, 4 and 1 months respectively postgrafting. In one patient, neuroblastoma cells in the initial tumour were described as 'pseudo-lymphomatous', and were therefore difficult to identify among the normal BM population. In two successive stagings, more than 10% of UJ13A positive isolated mononuclear cells were detected. Some of these cells (1-2%) were HSAN 1-2 positive on one occasion; this patient is clinically stable 3 months after the last staging procedure. The other 3 cases with clearly identified UJ13A positive cells are not clinically evaluable at this time.
A further 9 cases with UJ1 3A positivity also showed abnormality on both trephines and aspirates. In 8 patients, the immunological studies were in concordance with cyto-histology. For the ninth and as mentioned above, malignant cells clearly observed on aspirates were not identified either on cytological smears or immunological samples, suggesting the loss of malignant clumps on ficoll. Finally, the immunological results were also helpful in patients where the results of trephine biopsies and aspirates differed (11 cases). In 9 cases of this group trephines were classified as abnormal [) and aspirates normal. Immunological studies confirmed the presence of isolated tumour cells in 5/9 of these cases with further suggestive, but not conclusive, findings in favour of tumour cell involvement (i.e. -1% cells positive). In 2 cases where aspirates were found abnormal and trephines normal, immunological studies identified the malignant cells only in one case. Finally, in 3/56 cases, the immunological analysis of bone marrow was not possible with UJ13A and HSAN 1-2 antibodies since the initial tumour did not express the corresponding antigens.
Discussion
The accurate assessment of BM status is one of the important steps in the management of children with neuroblastoma. The metastatic spread may be focal. As a consequence the analysis of trephines and samples taken from several sites may improve diagnosis (Franklin et al., 1983; Bostrom et al., 1985; Bayle et al., 1985) . However, no study has attempted to define the number of sites and type of investigation that will maximize tumour cell detection without overloading the laboratory. From our study it appears that biopsies are more helpful at detecting malignant cells than aspirates. In 63.2% of pathological cases, biopsy was the only technique capable of demonstrating tumour, probably because neuroblastoma cells are less easily recognized when the clumps are dissociated. However, both techniques are necessary as in 13% of cases only aspirates were positive. The focal nature of the disorder was demonstrated by the fact that in 36.7% of cases only 1/8 assays (4 biopsies+4 trephines) were positive, indicating the need to analyse at least 4 sites by both methods. Nevertheless, the analysis of aspirates from additional sites such as sternum and tibia did not yield better detection. Analysis of trephine imprints was also unproductive. Furthermore, Bayle et al. (1985) suggested that cytocentrifuged smears of BM mononuclear cells should improve the detection of small aggregates of neuroblastoma cells, mainly by eliminating contaminating red cells. In our limited experience, analysis of these smears did not add useful observation to the diagnosis made on trephines and/or aspirates. Several authors have attempted to improve the detection rate of BM invasion by immunological methods (Reynolds et al., 1982; Kemshead et al., 1983) , and our study also demonstrates that immunological analysis improves cytological diagnosis since the immunological findings were pathological in 9 cases of positive biopsies with negative aspirates. In addition, as described for 11 cases in this study, immunological staining may detect neuroblastoma cells which are not yet recognizable by traditional cytological or histological criteria. Such cells need now to be fully characterized in their cytological aspect and membrane marker expression in order to investigate whether the presence of such cells precedes clinical relapse. The value of immunological analysis for the detection of minimal residual BM involvement should then lead to the further development of the procedure. Indeed, the MoAb panel used in this study was too restricted since it did not recognize malignant cells in 5% of cases; the MoAbs were not fully specific for neuroblastoma and for this reason it was difficult to ascertain whether <I % isolated positive cells were normal haematopoietic progenitors or neuroblastoma cells. Limitations of the method described here will be solved by using a larger panel of MoAbs, including some which recognize cytoplasmic antigens (Gross et al., 1986) and by characterizing their reactivity on neuroblastoma cells in trephine biopsies, as described by Chilosi et al. (1983) . This work was supported by grant no. 6519 from the Association pour la Recherche sur le Cancer (A.R.C.).
